Internal Medicine, Gastroenterology · Charlotte, NC
NPI
1598783961
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
300 Billingsley Rd Ste 200
Charlotte, NC, 28211
Phone (704) 372-7974
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
4,501 services
Medicare patients, 2024
754
Average age 74
Drug cost, 2024
$934K
2,422 prescriptions
Company payments, 2025
$40K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen E Deal was code 99439 (chronic, principal, and transitional care management), 1,847 times for 159 patients. In total Stephen E Deal billed 4,501 services in 53 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,847 | 159 | $37.91 | $70K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,029 | 160 | $49.21 | $51K |
| 99214 Office E&M - Established | Office | 297 | 232 | $92.72 | $28K |
| 99457 E&M - Miscellaneous | Office | 164 | 25 | $39.10 | $6,412 |
| 45385 Colonoscopy - Lesion Removal | Facility | 148 | 147 | $209.66 | $31K |
| 43239 Upper GI Endoscopy | Facility | 123 | 114 | $71.64 | $8,811 |
| 99454 E&M - Miscellaneous | Office | 104 | 22 | $36.64 | $3,811 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 91 | 90 | $176.80 | $16K |
| 99204 Office E&M - New | Office | 88 | 88 | $120.70 | $11K |
| 99213 Office E&M - Established | Office | 84 | 75 | $64.82 | $5,445 |
| 45380 Lower GI Endoscopy - Other | Facility | 64 | 64 | $120.36 | $7,703 |
| 43248 Upper GI Endoscopy | Facility | 50 | 44 | $115.12 | $5,756 |
| 99203 Office E&M - New | Office | 49 | 49 | $76.41 | $3,744 |
| 43274 Upper GI Endoscopy | Facility | 39 | 34 | $330.85 | $13K |
| 43264 Upper GI Endoscopy | Facility | 34 | 28 | $55.07 | $1,872 |
By year: 2022 $322K for 4,780 services; 2023 $340K for 5,557 services; 2024 $294K for 4,501 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen E Deal prescribed most often to Medicare patients was Pantoprazole Sodium, with 731 prescriptions and refills. In total Stephen E Deal wrote 2,422 Medicare prescriptions that cost $934K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 731 | 1,811 | 239 | $7,773 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 316 | 316 | 310 | $21K |
| Famotidine Generic | 142 | 307 | 44 | $1,867 |
| Omeprazole Generic | 133 | 380 | 51 | $2,049 |
| Linzess Linaclotide | 106 | 188 | 33 | $99K |
| Creon Lipase/Protease/Amylase | 105 | 131 | 24 | $351K |
| Dexlansoprazole Dr Dexlansoprazole | 63 | 123 | 18 | $21K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 60 | 60 | 57 | $783 |
| Esomeprazole Magnesium Generic | 54 | 110 | 15 | $3,004 |
| Balsalazide Disodium Generic | 53 | 122 | 16 | $17K |
| Budesonide Dr Budesonide | 51 | 77 | 15 | $5,428 |
| Lansoprazole Generic | 48 | 84 | 12 | $693 |
| Ursodiol Generic | 46 | 74 | Under 11 | $4,199 |
| Rabeprazole Sodium Generic | 40 | 109 | 13 | $1,784 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 35 | 35 | 34 | $5,736 |
Brand drugs: 516 claims; generic drugs: 1,906 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen E Deal $40K ($40K in general payments such as food, travel and fees) from 2 companies. The largest payer was Wilson Cook Medical Incorporated with $32K.
| Company | Payments | Amount |
|---|---|---|
| Wilson Cook Medical Incorporated | 3 | $32K |
| Cook Incorporated | 1 | $8,634 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.